{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:24:35Z","timestamp":1791815075497,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["8993"],"award-info":[{"award-number":["8993"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["962574"],"award-info":[{"award-number":["962574"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.intimp.2021.108493","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T20:54:05Z","timestamp":1642020845000},"page":"108493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line"],"prefix":"10.1016","volume":"104","author":[{"given":"Ali","family":"Asadirad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahmoud","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Dehnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ghanbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mortaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Anissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Asadzadeh Aghdaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7277-4484","authenticated-orcid":false,"given":"Davar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2021.108493_b0005","first-page":"297","article-title":"Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening: Cancer Screening in the US, 2018","volume":"68","author":"Smith","year":"2018","journal-title":"CA: A Cancer J. Clinicians"},{"issue":"11","key":"10.1016\/j.intimp.2021.108493_b0010","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/aje\/kwj324","article-title":"Dietary patterns and risk of colorectal tumors: a cohort of French women of the National Education System (E3N)","volume":"164","author":"Kesse","year":"2006","journal-title":"Am. J. epidemiol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of Dendritic Cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen Presentation and T Cell Stimulation by Dendritic Cells","volume":"20","author":"Guermonprez","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108493_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-021014-071641","article-title":"Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy","volume":"77","author":"Kourembanas","year":"2015","journal-title":"Annu. Rev. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108493_b0035","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.bcp.2011.12.037","article-title":"The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities","volume":"83","author":"Pant","year":"2012","journal-title":"Biochemical Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108493_b0040","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","article-title":"Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials","volume":"1820","author":"Vlassov","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"10.1016\/j.intimp.2021.108493_b0045","doi-asserted-by":"crossref","unstructured":"Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, et al. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. European journal of immunology. 2006 Jun;36(6):1598-607. PubMed PMID: 1670839Epub 2006\/05\/1eng.","DOI":"10.1002\/eji.200535501"},{"issue":"4","key":"10.1016\/j.intimp.2021.108493_b0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/vaccines3041019","article-title":"The dichotomy of tumor exosomes (TEX) in cancer immunity: is it all in the ConTEXt?","volume":"3","author":"Kunigelis","year":"2015","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.intimp.2021.108493_b0055","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4049\/jimmunol.172.4.2126","article-title":"Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I\/Peptide Complexes to Dendritic Cells","volume":"172","author":"Andr\u00e9","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2021.108493_b0060","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.mt.6300311","article-title":"MicroRNAs in disease and potential therapeutic applications","volume":"15","author":"Soifer","year":"2007","journal-title":"Mol. therapy : J. Am. Soc. Gene Therapy."},{"issue":"2","key":"10.1016\/j.intimp.2021.108493_b0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"cell"},{"key":"10.1016\/j.intimp.2021.108493_b0070","doi-asserted-by":"crossref","unstructured":"Lu C, Huang X, Zhang X, Roensch K, Cao Q, Nakayama KI, et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood. 2011 Apr 21;117(16):4293-303. PubMed PMID: 21355095. Pubmed Central PMCID: PMC3087479. Epub 2011\/03\/01. eng.","DOI":"10.1182\/blood-2010-12-322503"},{"issue":"41","key":"10.1016\/j.intimp.2021.108493_b0075","doi-asserted-by":"crossref","first-page":"31876","DOI":"10.1074\/jbc.M110.118877","article-title":"Identification of a Novel Marker for Dendritic Cell Maturation, Mouse Transmembrane Protein 123","volume":"285","author":"Takekoshi","year":"2010","journal-title":"J. Biological Chem."},{"issue":"6","key":"10.1016\/j.intimp.2021.108493_b0080","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.3390\/molecules17066557","article-title":"Maturation of Murine Bone Marrow-Derived Dendritic Cells Induced by Radix Glycyrrhizae Polysaccharide","volume":"17","author":"Li","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2021.108493_b0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.lfs.2019.01.005","article-title":"Phenotypical and functional evaluation of dendritic cells after exosomal delivery of miRNA-155","volume":"219","author":"Asadirad","year":"2019","journal-title":"Life Sciences"},{"key":"10.1016\/j.intimp.2021.108493_b0090","doi-asserted-by":"crossref","unstructured":"Seliger B, Ruiz-Cabello F, Garrido F. IFN inducibility of major histocompatibility antigens in tumors. Advances in cancer research. 2008;101:249-76. PubMed PMID: 19055946. Epub 2008\/12\/06. eng.","DOI":"10.1016\/S0065-230X(08)00407-7"},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.2008.00707.x","article-title":"Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms","volume":"226","author":"Hu","year":"2008","journal-title":"Immunological reviews"},{"issue":"4","key":"10.1016\/j.intimp.2021.108493_b0100","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1002\/ijc.29100","article-title":"Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice: Tumor exosomes and immunotherapy","volume":"136","author":"Gu","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2021.108493_b0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.canlet.2008.10.021","article-title":"MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models","volume":"275","author":"Cho","year":"2009","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2006.02483.x","article-title":"Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity","volume":"120","author":"Hao","year":"2007","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2021.108493_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.108493_b0120","doi-asserted-by":"crossref","unstructured":"Escudier B, Dorval T, Chaput N, Andre F, Caby MP, Novault S, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. Journal of translational medicine. 2005 Mar 2;3(1):10. PubMed PMID: 15740633. Pubmed Central PMCID: PMC554765. Epub 2005\/03\/03. eng.","DOI":"10.1186\/1479-5876-3-10"},{"issue":"2","key":"10.1016\/j.intimp.2021.108493_b0125","first-page":"393","article-title":"Vaccination with dendritic cell\/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma","volume":"117","author":"Rosenblatt","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108493_b0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.immuni.2014.03.014","article-title":"miR-155 Activates Cytokine Gene Expression in Th17 Cells by Regulating the DNA-Binding Protein Jarid2 to Relieve Polycomb-Mediated Repression","volume":"40","author":"Escobar","year":"2014","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2021.108493_b0135","first-page":"2043","article-title":"Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression","volume":"62","author":"Huang","year":"2002","journal-title":"Cancer research."},{"issue":"6236","key":"10.1016\/j.intimp.2021.108493_b0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.aaa3828","article-title":"A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells","volume":"348","author":"Carreno","year":"2015","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.intimp.2021.108493_b0145","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-03-3505","article-title":"Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma","volume":"64","author":"Yu","year":"2004","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.intimp.2021.108493_b0150","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nm1295-1297","article-title":"Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity","volume":"1","author":"Mayordomo","year":"1995","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.intimp.2021.108493_b0155","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1158\/1078-0432.CCR-07-0517","article-title":"Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth","volume":"13","author":"Zhong","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921011292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921011292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:32:28Z","timestamp":1761586348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921011292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"alternative-id":["S1567576921011292"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108493","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell immunotherapy with miR-155 enriched tumor-derived exosome suppressed cancer growth and induced antitumor immune responses in murine model of colorectal cancer induced by CT26 cell line","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108493"}}